| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 08/27/2008 | EP1961750A1 Vla-4 inhibitory drug |
| 08/27/2008 | EP1961749A1 Acid addition salt of dihydropyridine derivative |
| 08/27/2008 | EP1961748A2 2-hydroxy-3-heteroarylindole derivatives as GSK3 inhibitors |
| 08/27/2008 | EP1960395A1 Plasminogen activator inhibitor-1 inhibitors |
| 08/27/2008 | EP1960391A1 Piperazine derivatives and their use in therapy |
| 08/27/2008 | EP1960390A1 Biaryl compounds useful as agonists of the gpr38 receptor |
| 08/27/2008 | EP1960389A2 Compounds which have activity at m1 receptor and their uses in medicine |
| 08/27/2008 | EP1960388A1 Processes for preparing substantially pure pantoprazole magnesium |
| 08/27/2008 | EP1960387A1 Isoquinoline et benzo[h]isoquinoline derivatives, preparation and therapeutic use thereof as antagonists of histamine h3 receptor |
| 08/27/2008 | EP1960386A2 Substituted cycloalkylpyrrolones as allosteric modulators of glucokinase |
| 08/27/2008 | EP1960385A1 Substituted dihydroisoindolones as allosteric modulators of glucokinase |
| 08/27/2008 | EP1960384A1 New process for the preparation of esomeprazole non-salt form |
| 08/27/2008 | EP1960383A1 5-substituted indole-2-carboxamide derivatives |
| 08/27/2008 | EP1960382A1 Heterocyclic compounds as tyrosine kinase modulators |
| 08/27/2008 | EP1960381A1 Aminophenylsulfonamide derivatives as hiv protease inhibitor |
| 08/27/2008 | EP1960380A1 F,g,h,i and k crystal forms of imatinib mesylate |
| 08/27/2008 | EP1960373A2 Novel quinoxaline derivatives and their medical use |
| 08/27/2008 | EP1960368A1 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between p53 and mdm2 proteins for use as anticancer agents |
| 08/27/2008 | EP1960367A2 Substituted pyrazole compounds useful as soluble epoxide hydrolase inhibitors |
| 08/27/2008 | EP1960365A2 Azonafide derivatives, methods for their production and pharmaceutical compositions therefrom |
| 08/27/2008 | EP1960363A2 Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereof |
| 08/27/2008 | EP1960359A1 Novel n-sulfamoyl-piperidineamides for the prophylaxis or treatment of obesity and related conditions |
| 08/27/2008 | EP1960355A1 3-amino-1-arylpropyl indoles and aza-substituted indoles |
| 08/27/2008 | EP1960347A2 17-beta-hydroxysteroid dehydrogenase type 3 (17beta-hsd3) inhibitors |
| 08/27/2008 | EP1858881B1 Process for the preparation of optically active derivatives of 2-(2-pyridylmethylsulfinyl)-benzimidazole via inclusion complex with 1,1'-binaphthalene-2, 2'diol |
| 08/27/2008 | EP1708996B1 Fused heteroyral derivatives for use as p38 kinase inhibitors |
| 08/27/2008 | EP1697318B1 Prolinylarylacetamides |
| 08/27/2008 | EP1654255B1 Substituted indazolyl(indolyl)maleimide derivatives as kinase inhibitors |
| 08/27/2008 | EP1638953B1 3-substituted 5,6-diaryl-pyrazine-2-carboxamide and -2-sulfonamide derivatives as cb1 modulators |
| 08/27/2008 | EP1625114B1 Piperidine derivatives for the the treatment of chemokine or H1 mediated diseases |
| 08/27/2008 | EP1622569A4 Aza spiro alkane derivatives as inhibitors of metallproteases |
| 08/27/2008 | EP1474146B1 Phenylpyrimidine amines as ige inhibitors |
| 08/27/2008 | EP1368325B1 New asymmetric process for the preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates |
| 08/27/2008 | EP0952832B1 Quinoline carboxamides as tnf inhibitors and as pde-iv inhibitors |
| 08/27/2008 | CN101253172A N-linked heterocyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
| 08/27/2008 | CN101253170A Compound having triazole ring structure substituted with pyridyl group and organic electroluminescent device |
| 08/27/2008 | CN101253169A Substituted benzimidazoles and methods of preparation |
| 08/27/2008 | CN101253168A Substituted benzimidazoles as kinase inhibitors |
| 08/27/2008 | CN101253167A Substituted imidazole compounds as KSP inhibitors |
| 08/27/2008 | CN101253166A Sulfonamide compound |
| 08/27/2008 | CN101253165A Di-substituted oxadiazoles as CXC-chemokine receptor ligands |
| 08/27/2008 | CN101253164A Indol-3-carbonyl-spiro-piperidine derivatives as v1a receptor antagonists |
| 08/27/2008 | CN101253163A Processes for the preparation of 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione compounds |
| 08/27/2008 | CN101253159A Diaminopyrimidines as P2X3 and P2X2/3 modulators |
| 08/27/2008 | CN101253153A 6-substituted-2,3,4,5-tetrahydro-1H-benzo[d] azepines as 5-HT2c receptor agonists |
| 08/27/2008 | CN101253152A Amide derivatives as ROCK inhibitors |
| 08/27/2008 | CN101253151A GPCR agonists |
| 08/27/2008 | CN101253147A Organic compounds |
| 08/27/2008 | CN101252930A Isoquinoline compounds and methods of use thereof |
| 08/27/2008 | CN101252929A G-protein coupled receptor agonists |
| 08/27/2008 | CN101250183A Optical isomer of rebeprazole as well as preparation method and medical use thereof |
| 08/27/2008 | CN101250182A Lansoprazole sodium |
| 08/27/2008 | CN101250181A S-pantoprazole sodium |
| 08/27/2008 | CN101250180A Amorphous S-pantoprazole sodium, preparation method and use thereof |
| 08/27/2008 | CN101250166A Thiadiazoles formamide derivative as well as synthesis and uses thereof |
| 08/27/2008 | CN101250161A 3-oxo imidazole compounds and method for synthesizing same |
| 08/27/2008 | CN101249269A Integrin targeted imaging agents |
| 08/27/2008 | CN100413860C Piperidine derivative as NMDA receptor antagonist |
| 08/27/2008 | CN100413850C Chemical compounds |
| 08/27/2008 | CN100413849C Benzimidazole derivatives |
| 08/27/2008 | CN100413539C The use of 5ht4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions |
| 08/26/2008 | US7417152 4-Bromo-5-(2-chloro-benzoylamino)-1H-pyrazole-3-carboxylic acid (2-pyrrolidin-1-yl-ethyl)-amide; 5-(2-chlorobenzoylamino)-1H-pyrazole-3-carboxylic acid {2-[4-(4,5-dihydro-1H-imidazol-2-yl)-phenyl]ethyl}amide; useful for the moderation of pain, septic shock, and scarring |
| 08/26/2008 | US7417150 Azoles having an insecticidal action |
| 08/26/2008 | US7417063 of the coagulation cascade or contact activation system: thrombin, factor Xa, factor XIa, factor IXa, factor VIIa or plasma kallikrein; e.g. -(6-carbamimidoyl-1H-indol-3-ylmethyl)-4-methoxy-biphenyl-2-carboxylic acid; anticoagulant, antiinflammatory agent |
| 08/26/2008 | US7417057 insecticides; safe for crops; Fused partially unsaturated carbocyclic or heterocyclic ring substituted with a 5-or 6-membered heterocyclic ring such as imidazole, thiazole, oxazole, 1,3,4-oxadiazole |
| 08/26/2008 | US7417052 Phenylene derivative having tetrazole ring or thiazolidinedione ring |
| 08/26/2008 | US7417050 Cognition activators; Alzheimer's disease; attention deficit disorders; Parkinson's disease; Huntington's disease; neurodegenerative disease |
| 08/26/2008 | US7417049 Furyl compounds |
| 08/26/2008 | US7417047 Amino-5-(5-membered)hetero-arylimidazolone compounds and the use thereof for β-secretase modulation |
| 08/26/2008 | US7417046 Inhibiting the proteolytic activity of cathepsin S; 1-[4-(5-Chloro-1H-indol-3-yl)-piperazine-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol; antiarthritic agent; autoimmune disease: lupus, rheumatoid arthritis, and asthma |
| 08/26/2008 | US7417042 Peptide-based compounds include at least three peptide units, an epoxide or aziridine, and functionalization at the N-terminus inhibit specific activities of N-terminal nucleophile (Ntn) hydrolases, e.g., the chymotrypsin-like activity of the 20S proteasome; antiproliferative and antiinflammatory agents |
| 08/26/2008 | US7417041 Imidazopyrimidines as transforming growth factor (TGF) inhibitors |
| 08/26/2008 | CA2432129C Pyrazole compounds useful as protein kinase inhibitors |
| 08/26/2008 | CA2329230C A process for the manufacture of sulfonylaminocarbonyl triazolinones in the presence of xylene as solvent |
| 08/26/2008 | CA2274825C Substituted nitrogen containing heterocycles as inhibitors of p38 protein kinase |
| 08/21/2008 | WO2008101247A2 6 ' substituted indole and indazole derivatives having 5-ht6 receptor affinity |
| 08/21/2008 | WO2008101139A1 Sustained-release tablet formulations of piperazine-piperidine antagonists and agonists of the 5-ht1a receptor having enhanced intestinal dissolution |
| 08/21/2008 | WO2008100867A2 Novel inhibitors hepatitis c virus replication |
| 08/21/2008 | WO2008099794A1 Fused ring compounds as partial agonists of ppar-gamma |
| 08/21/2008 | WO2008099210A2 Piperazine derivatives for treatment of ad and related conditions |
| 08/21/2008 | WO2008099083A2 Use of neuroprotective compounds for obtaining drugs for treating neurodegenerative diseases |
| 08/21/2008 | WO2008099076A2 Substituted n-(4-cyano-1h-pyrazol-3-yl)methylamine derivatives, preparation thereof and therapeutic use thereof |
| 08/21/2008 | WO2008099075A1 2-anilino-4-heteroaryl pyrimidine derivatives, and preparation thereof as medicaments, pharmaceutical compositions, and in particular ikk inhibitors |
| 08/21/2008 | WO2008099074A1 Phenyl- (4-phenyl-pyrimidin-2-yl) - amine derivatives as ikk inhibitors, preparation thereof, and pharmaceutical compositions thereof |
| 08/21/2008 | WO2008099073A1 N, n' -2, 4-dianilinopyrimidines preparation and use thereof as ikk inhibitors preparation and teh pharmacuetical compositions thereof |
| 08/21/2008 | WO2008099022A1 10-sulfonyl-dibenzodiazepinones useful as hepatitis c virus inhibitors |
| 08/21/2008 | WO2008099019A1 6-hydroxy-dibenzodiazepinones useful as hepatitis c virus inhibitors |
| 08/21/2008 | WO2008098859A1 Hcv polymerase inhibitors |
| 08/21/2008 | WO2008098798A1 Tetrahydronaphthalenylamides, a process for their production and their use as anti-inflammatory agents |
| 08/21/2008 | WO2008068614A3 Stereoselective synthesis of 1-[6-ethyl-1,2-dihydroxy-propyl)-pyridin-3-yl]-3-[2-(4-methyl-piperazin-1-yl)-benzyl]-pyrrolidin-2-one |
| 08/21/2008 | WO2008057291B1 Crystalline and amorphous imatinib base, imatinib mesylate- and processes for preparation thereof |
| 08/21/2008 | WO2008034736A3 Oxindole derivatives as anticancer agents |
| 08/21/2008 | WO2008033562A3 Kinase inhibitor compounds |
| 08/21/2008 | WO2008031550A3 Nicotinic acid derivatives as modulators of metabotropic glutanate receptors |
| 08/21/2008 | WO2008019357A3 Indole compounds |
| 08/21/2008 | WO2007139955A3 Triazole compounds that modulate hsp90 activity |
| 08/21/2008 | WO2007020261A3 Selected cgrp antagonists, methods for the production thereof and their use as medicaments |
| 08/21/2008 | US20080200524 Treating pain, inflammation and traumatic injury; using 2-pyridinyl-phenyl-4-amido-p-sulfono or sulfonamidobenzene derivatives |
| 08/21/2008 | US20080200519 5-Amino-1-(4-fluorophenyl)-N-[6-fluoro-1,2,3,4-tetrahydro-2-hydroxy-5-methoxy-4,4-dimethyl-2-(trifluoromethyl)naphthalene-1-yl]-1H-pyrazole-4-carboxamide; selectivity to glucocorticoid receptor; fewer side effect; inhibit secretion of cytokine IL-8 into monocyte cell line THP-1 triggered by lipopolysacch |
| 08/21/2008 | US20080200517 Racemic 2[[(4-methoxy-3-methyl-2-pyridinyl)-methyl]sulfinyl]-5-(1H-pyrrol-1-yl)-1H-benzimidazole (ilaprazole) solvates having distinctive x-ray powder diffraction patterns and DSC thermograms; inhibiting gastric acid secretion; gastrointestinal inflammatory disorders; solubility, stability |